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Abstract
Difference in differences require that 0% of observations are treated in the control group
and during period 0 (no "always takers") and 100% in the treatment group in period 1
(no "never takers"). Sometimes, the treatment rate increases more in the treatment
than in the control group but there are never or always takers. This paper develops
results to identify treatment effects in such settings. They only require one common trend
assumption on the outcome of interest Y whereas the standard instrumental variable result
also requires common trend on treatment D. I derive bounds for treatment effects which
are tight when there are no or few always takers. This can be the case in applications
considering the effect of an innovation, where by definition no observations are treated in
period 0. I derive other bounds that are tight when the treatment rate does not change
much between the two periods in the control group, which can be the case in applications
considering the extension of a program to a group previously not eligible. I use my results
to measure the efficacy of a new drug for smoking cessation.
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1 Introduction
Differences in differences (DID) are commonly used to estimate average treatment effects on
the treated (ATT) when treatment D is not randomly allocated. DID compare the evolution
of the mean of some outcome Y between two periods (0 and 1) and across two groups of
individuals (control and treatment). In Rubin’s causal model (Rubin (1974)) where potential
outcomes with and without treatment (Y (1) and Y (0)) are introduced, and where treatment
effects are allowed to be heterogeneous across observations, a DID identifies an ATT under two
assumptions. The first one is a common trend assumption which states that if all observations
had remained untreated the mean of Y would have followed parallel trends from period 0 to
1 in the two groups (see e.g. Abadie, 2005). The second one, which is implicit, is a perfect
compliance assumption: the treatment rate should be equal to 0% in the control group and
during period 0 (no "always takers") and to 100% in the treatment group in period 1 (no
"never takers").1 In many instances, this last assumption is violated: the treatment rate
increases more in the treatment than in the control group but there are "never" or "always"
takers.2 This differential change in treatment rate across the control and the treatment group
might still be used to identify an ATT.
The starting point of the paper is that when compliance is imperfect, common trend alone
is not sufficient for identification in a model allowing for heterogeneous treatment effects.
In a standard DID, if the common trend assumption on Y (0) holds, the only reason why
trends might diverge across groups is that observations in the treatment group × period 1
cell get treated, so that the DID measures the effect of the treatment on them. A DID
computation will therefore yield one equation with only one unknown. In a fuzzy DID, since
there might be treated observations in each of the four time × group cells, diverging trends
can potentially arise from the effect of the treatment within each of those four subgroups and
a DID computation will yield one equation with up to four unknowns. The identification
problem arises because Y (1)− Y (0) is allowed to vary across observations, implying that the
1In this paper, never takers are merely untreated observations in the period 1 × treatment group cell.
Always takers are treated observations in the three other cells. Therefore, my definition of always and never
takers does not exactly correspond to the definition of Imbens & Angrist (1994), but I still use their terminology
to clarify the exposition.
2When panel data is available, one option to avoid this issue could be to use treatment status in period 0 and
1 to define the treatment and the control groups, instead of using presumably stable observable characteristics.
One could for instance define all observations untreated in period 0 and 1 to be the control group, and all
observations untreated in period 0 and treated in period 1 to be the treatment group (see for instance Field
(2005)). However, when groups are constructed this way, common trend might not hold, for instance because
untreated individuals in period 0 may decide to get treated in period 1 if they expect a negative shock on their
Y (0).
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effect of the treatment might vary across cells.
However, when there are no always takers, I show in Theorem 2.1 that the common trend
assumption is sufficient to identify an ATT because there are treated observations in one group
only, so that the DID computation yields one equation with one unknown. Applications with
no always takers arise frequently in practice. They correspond to situations where it is possible
to isolate one group excluded from treatment both in period 0 and 1 based on observable
characteristics, while it is not possible to isolate a group fully treated in period 1. This can
happen for various reasons: eligibility criteria might be too complex to determine exactly the
eligible population, or some eligible individuals might deny the treatment. A good example is
Eissa & Liebman (1996).3
When there are always takers, common trend on Y (0) does not allow for point identifi-
cation, but partial identification of an ATT in the spirit of Manski (1990) is still possible,
provided Y is bounded. In Theorem 2.2, I derive sharp bounds in this case. Those bounds
will be tight when there are "few" always takers. I illustrate what "few" means in the next
section through a simple numerical example. For now, one can keep in mind as a rough rule
of thumb that those bounds can be relatively tight when the sum of the shares of observa-
tions treated in the three supposedly untreated cells is below 10%. This is likely to happen
in applications considering the effect of an innovation released in period 1. Indeed, in such
applications nobody is treated in period 0. Therefore, bounds will be tight if it is possible to
find a control group in which less than 10% of observations benefited from the innovation in
period 1. A good example is the application used in this paper. Varenicline is a drug which
was made available to French smoking cessation clinics in February 2007. In 15 clinics, less
than 3% of all patients consulted have been prescribed varenicline during the year following
its release. In 13 clinics, more than 20% of patients received it. Overall, 38% of patients
received this new drug in the treatment clinics in period 1, against 2% in the control clinics.
I use Theorem 2.2 to derive bounds for the average effect of varenicline on smoking cessation.
Since in this application there are very few always takers, those bounds are narrow.
Then, I derive a second couple of sharp bounds for the same ATT under the supplementary
assumption that the response to treatment is monotone (i.e. Y (1) ≥ Y (0)) as in Manski (1997).
3To measure the effect of EITC extension on female labor market participation, Eissa & Liebman (1996)
use single women without children as a control group, and lone mothers as the treatment group. By definition,
their control group is excluded from treatment both in period 0 and 1. Moreover, treatment is not available
to the treatment group in period 0. Therefore, they do not have always takers in their analysis. However,
not all lone mothers are eligible to EITC extension in period 1 because this program is means tested. Exact
eligibility criteria are too complex for them to isolate eligible lone mothers. Moreover, it is likely that not all
lone mothers eligible applied for EITC. Therefore, they have never takers.
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Those bounds partly dispose of the bounded support assumption since they only require that
Y (0) is bounded by below. Therefore, they apply for instance to wages, while the previous
ones do not. The size of the resulting identification region also depends on the shares of always
takers. I show in a numerical example that it is roughly twice smaller than the first one.
Finally, I derive a third couple of sharp bounds under the assumption that treatment
effects do not change between the two periods in the control group. The size of the resulting
identification region now depends on the share of treated observations in the treatment group
in period 0, and on the change in the treatment rate from period 0 to 1 in the control group.
I show through a numerical example that when there are no treated observations in the
treatment group in period 0, those bounds will be relatively tight as long as the treatment
rate does not change by more than roughly 10 percentage points in the control group. This
is likely to be the case in applications considering the extension of a public policy to a group
previously not eligible to it, and where the previously eligible group is used as a control group
(see for instance Bach, 2010).
Common trend is a strong identifying assumption which might appear implausible if pre-
treatment characteristics that are thought to be associated to the dynamics of the outcome
variable are unbalanced between the treatment and the control groups (see Abadie, 2005). In
such instances, a conditional common trend assumption might appear more credible. There-
fore, I also derive fuzzy semi-parametric DID results inspired from Abadie (2005), which allow
to control semi-parametrically for covariates. All the results obtained under common trend
can be extended under conditional common trend.
Many empirical papers have already used a greater increase of the treatment rate in one
group as a source of variation to identify treatment effects. Up to now, researchers who
implemented this strategy estimated the impact of the treatment through an instrumental
variable (IV) regression using the interaction of time and group as an instrument for treatment.
The resulting coefficient is the DID on Y divided by the DID on D. I hereafter refer to this
strategy as an IV-DID. Duflo (2001) uses an IV-DID to estimate the impact of educational
attainment on wages. There are also a very large number of papers which use differential
evolution of exposure to treatment across US states to estimate treatment effects. A good
example is Evans & Ringel (1999) who use changes in cigarette taxes across US states as an
instrument for smoking prevalence among pregnant women, in order to estimate the impact
of smoking during pregnancy on newborns’ weight.
Imbens & Angrist (1994) have shown that IV coefficients can be interpreted as local average
treatment effects (LATE) in a model allowing for heterogeneous treatment effects. I put
forward in a companion note (de Chaisemartin (2011)) that when applied to IV-DID, their
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result holds under a common trend assumption on Y (0) but also on D(0) (the potential
treatment without the instrument), and a monotonicity assumption which states that there
should be no "defiers". Common trend on Y (0) ensures that the DID on Y recovers the
intention to treat effect of the policy, whereas common trend on D(0) and monotonicity
ensure that the DID on D is equal to the share of compliers, so that the ratio of the two is
indeed equal to a LATE.
My results contribute to the literature firstly because they remove the monotonicity condi-
tion which may be restrictive in some applications.4 More importantly, my results hold under
a common trend assumption on Y (0) only, and not on D(0). There are two reasons why
disposing of the common trend assumption on D(0) while maintaining it on Y (0) might be
appealing. Firstly, in many IV-DID applications, common trend on D(0) is less credible than
common trend on Y (0). For instance, the identifying assumption in Evans & Ringel (1999) is
that both mothers’ smoking rates and newborns’ weight would have followed parallel trends
in states where taxes on tobacco increased and in other states if taxes had not increased. But
it may be the case that states which choose to rise taxes on cigarettes do so because they
face an increasing trend in smoking, whereas there is no reason to suspect that this decision
is related to trends on other determinants of newborns weight.
Secondly, there are applications in which taking a common trend assumption on D(0) is
merely problematic. For instance, in applications considering the extension of a public policy,
common trend on D(0) means that if the policy had not been extended to the treatment
group in period 1, the treatment rate would have followed the same trends in the control and
in the treatment groups. But if the policy had not been extended, the treatment rate would
merely have been equal to 0% at both periods in the treatment group. Therefore, common
trend on D(0) will be violated as soon as the treatment rate slightly changes in the control
group. In applications considering the introduction of an innovation, common trend on D(0)
is problematic as well. Take for instance the application developed in this paper. Treatment
rate was equal to 0% in the two groups of clinics in period 0. Therefore, common trend on
D(0) means that if treatment group patients had gone to a control clinic in period 1, 2%
of them would have received varenicline as well, exactly as what indeed happened to control
group patients. Since allocation of patients to clinics was not random, this assumption is
unlikely to hold.
4A good example is Angrist & Evans (1998), where the authors use the fact that parents show preferences for
a mixed sibling-sex composition as an instrument to estimate the effect of childbearing on females labor supply.
Even though parents might on average display such preferences, it is not impossible that some parents have
the opposite preferences, so that the monotonicity assumption might hold on average but not with probability
one.
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Importantly, the bounds identified in this paper are very simple to estimate. They can
be estimated through OLS regressions on slightly modified versions of Y , which essentially
amount to replace always takers’ Y by the lower or upper endpoint of the support of Y (0).
Inference is more involved, because of all the complications arising when conducting inference
on partially identified parameters (see e.g. Imbens & Manski (2004)). However, a recent
method developed by Andrews & Soares (2010) readily applies to my setting.
The remainder of the paper is organized as follows. Section 2 is devoted to identification.
Section 3 deals with inference. Section 4 is devoted to the application. Section 5 concludes.
2 Identification
Let T ∈ {t0; t1} denote time and G ∈ {gc; gt} denote treatment (gt) and control (gc) groups.
Results apply irrespective of whether panel or pooled cross-sections data are available. Treat-
ment status is binary and is denoted by an indicator D.5 Let Y (1) and Y (0) be the poten-
tial outcomes of an individual with and without the treatment. Only the actual outcome
Y = Y (1)×D + Y (0)× (1−D) is observed. The individual treatment effect is Y (1)− Y (0).
For any random variables Z andW , Z ∼W means that Z andW have the same probability
distribution. Z is the support of Z. To alleviate the notational burden, I introduce the
following shorthand taken from Athey & Imbens (2006):
∀(i, j) ∈ {t0; t1} × {gc; gt} , Zi,j ∼ Z| t = i, g = j.
Under those notations, ∀(i, j) ∈ {t0; t1} × {gc; gt} , ATTi,j = E(Yi,j(1) − Yi,j(0)|D = 1) is
the average treatment effect on treated individuals of group j in period i. My parameter of
interest is ATTt1,gt , which is the average treatment effect among treated observations in the
(t1; gt) cell. This population is directly identified from the data (provided D is observed) and
can be easily characterized.
The DID of a random variable Z is denoted
DIDZ = E(Zt1,gt)− E(Zt0,gt)− [E(Zt1,gc)− E(Zt0,gc)] .
I assume that DIDD, the DID on treatment rate, is different from 0: treatment rate should
not follow the same evolution in the two groups. Without loss of generality, I assume that
DIDD > 0. I denote
PAT = P(Dt0,gt = 1) + P(Dt1,gc = 1) + P(Dt0,gc = 1)
5The analysis can easily be extended when treatment is multivariate in the spirit of Angrist & Imbens
(1995). Results are not presented here due to a concern for brevity but are available upon request.
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the sum of the three shares of always takers. The "no always takers" special case is when
PAT = 0, i.e. when there are no treated observations in any of the supposedly untreated cells.
As detailed in the introduction, this special case is important in practice.
I take a common trend assumption which is at the basis of the DID approach (see for
instance Abadie (2005)):
A.1 Common trend
E(Yt1,gt(0))− E(Yt0,gt(0)) = E(Yt1,gc(0))− E(Yt0,gc(0)).
This common trend assumption can be rationalized by a DGP for potential outcomes addi-
tively separable in time and group:
Y (d) = fd(T,U) + gd(G,U),
where U represents unobserved heterogeneity and U ⊥⊥ (T,G) (see e.g. Athey & Imbens
(2006)). I can now state the lemma which is at the core of all results in the paper:
Lemma 2.1 Non-identification
Under A.1, none of the ATTi,j is identified and
DIDY = ATTt1,gt × P(Dt1,gt = 1)−ATTt0,gt × P(Dt0,gt = 1)
−ATTt1,gc × P(Dt1,gc = 1) +ATTt0,gc × P(Dt0,gc = 1).
(1)
According to Lemma 2.1, under A.1 DIDY can be written as a weighted DID of four
average treatment effects. Because two ATT enter the equation with positive sign and two
with negative sign, DIDY cannot be given any causal interpretation. It might for instance be
positive whereas the four ATT are negative.
The intuition for this result is as follows. According to A.1, if no observations had been
treated in any of the four time × group cells, trends would have been parallel in the two
groups, and DIDY would have merely been equal to 0. In a standard DID, if A.1 holds then
the only reason why trends might diverge across groups is that observations in the treatment
group get treated in period 1, so that DIDY measures the effect of the treatment on them. In
a fuzzy DID, since there might be treated observations in several time × group cells, diverging
trends can potentially arise from the effect of the treatment in each of those cells. Then, if
no restrictions are placed on how heterogeneous the treatment effect can be across these four
cells, it is not possible to identify any of the ATTi,j from a standard DID computation, since
it yields one equation with four unknowns. From this Lemma, I derive Theorems 2.1 to 2.4.
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Theorem 2.1 Point identification
1. Under A.1, in the no always takers special case,
ATTt1,gt =
DIDY
P(Dt1,gt = 1)
.
2. Under A.1, if ∀(i, j) ∈ {t0; t1} × {gc; gt} , ATTi,j = ATTt1,gt , ATTt1,gt is identified:
ATTt1,gt =
DIDY
DIDD
.
In the no always takers special case, there are treated observations in one group only, and
only one unknown left in (1). Therefore, A.1 is sufficient to identify an average treatment
effect, as in a standard DID.6 This average treatment effect is ATTt1,gt , the average effect of
the treatment among treated observations in the (t1; gt) cell. Estimating it still requires being
able to estimate P(Dt1,gt = 1). But sometimes treatment status is not observed. In such
instances, since ATTt1,gt and DIDY have the same sign and |DIDY | ≤ |ATTt1,gt |, it is at
least possible to estimate a lower bound of ATTt1,gt by computing DIDY . For instance, Eissa
& Liebman (1996) do not observe treatment status, so that they cannot estimate DIDYP(Dt1,gt=1) .
They estimate instead DIDY , and find that participation to the labor market increased by
1.4 percentage points more among lone mothers than among single women without children
following the extension of the EITC. The first point in Theorem 2.1 allows to interpret this
1.4 percentage points DID as a lower bound to the true effect of the EITC extension on labor
market participation among lone mothers who benefited from it.
The second point of Theorem 2.1 shows that even when there are always takers, ATTt1,gt
is also identified if one is ready to assume that treatment effects do not vary across time and
group. This is because under this assumption the four unknowns in (1) are equal to each
other. But this is fairly restrictive an assumption. The underlying assumption to a fuzzy DID
is indeed that treatment rate increased more from period 0 to 1 in the treatment group than
in the control group. This might for instance be because treatment group individuals were
more incentivized to receive the treatment in period 1 than in period 0. Inside the treatment
group, treated individuals during period 1 are therefore likely to differ from those treated
during period 0 so that the average treatment effect could arguably be different in these two
6This is similar to the result on regression discontinuity (RDD) obtained by Battistin & Rettore (2008).
They indeed show that in a fuzzy RDD, when treatment rate is equal to 0 below the eligibility threshold, so
that fuzziness arises only because of never takers (i.e. untreated individuals above the threshold), identification
is obtained under the same assumptions than in a sharp RDD.
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groups. Therefore, I give now three partial identification results which do not require this
"constant treatment effect" assumption.
After some algebra, (1) rewrites as
ATTt1,gt =
E(Yt1,gt)− E(Yt0,gt(0))− E(Yt1,gc(0)) + E(Yt0,gc(0))
P(Dt1,gt = 1)
. (2)
This implies that ATTt1,gt would be identified if the mean of Y (0) was observed in the (t0; gt),
(t1; gc) and (t0; gc) cells. Therefore ATTt1,gt is not identified when there are treated obser-
vations in those cells, because their Y (0) is not observed. But when Y (0) is bounded, it is
possible to bound those unobserved Y (0) to derive some bounds for ATTt1,gt . This is what I
do in Theorem 2.2.
Before stating Theorem 2.2, I define three indicator variables. ATt0,gt = 1{D=1,T=t0,G=gt}
corresponds to treated observations in the (t0; gt) cell, ATt1,gc = 1{D=1,T=t1,G=gc} to treated
observations in the (t1; gc) cell, and ATt0,gc = 1{D=1,T=t0,G=gc} to treated observations in the
(t0; gc) cell. I define the following random variables which are functions of Y , D, T , G, M
and m, where m and M are real numbers defined below:
Y 0− = Y + (M − Y ) (ATt0,gt +ATt1,gc) + (m− Y )ATt0,gc
and
Y 0+ = Y + (m− Y ) (ATt0,gt +ATt1,gc) + (M − Y )ATt0,gc .
Y 0− merely replaces Y by M for treated observations in the (t0; gt) and (t1; gc) cells, and
by m for treated observations in the (t0; gc) cell, while it leaves Y unchanged for all remaining
observations. Y 0+ performs the same replacements except that M and m are switched.
Theorem 2.2 Partial identification 1
Under A.1, if P(m ≤ Y (0) ≤M) = 1, with (m,M) ∈ R2,
B− ≤ ATTt1,gt ≤ B+,
with
B− = max
(
E(Yt1,gt |D = 1)−M ;
DIDY 0−
P(Dt1,gt = 1)
)
and
B+ = min
(
E(Yt1,gt |D = 1)−m;
DIDY 0+
P(Dt1,gt = 1)
)
.
B− and B+ are sharp.
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B− is obtained as follows. Firstly, boundedness of Y (0) trivially implies that
E(Yt1,gt |D = 1)−M ≤ ATTt1,gt .
Secondly, the only unobserved quantities in (2) are E(Yt0,gt(0)|D = 1), E(Yt1,gc(0)|D =
1) and E(Yt0,gc(0)|D = 1). Therefore, using the fact that m ≤ E(Yt0,gt(0)|D = 1), m ≤
E(Yt1,gc(0)|D = 1) and E(Yt0,gc(0)|D = 1) ≤ M, and plugging those three inequalities into
(2) yields another lower bound for ATTt1,gt . Finally, B− is defined as the max of those two
lower bounds.
Interestingly, one can show that the second lower bound writes as
DIDY 0−
P(Dt1,gt = 1)
.
This expression is similar to the formula obtained in point 1 of Theorem 2.1, except that the
DID is no longer computed on Y but on Y 0−. Y 0− replaces Y by M for treated observations in
the (t0; gt) and (t1; gc) cells, and by m for treated observations in the (t0; gc) cell. Therefore,
DIDY 0− is the lowest possible value of the numerator of equation (2). DIDY 0− can be estimated
through the following OLS regression:
Y 0− = α+ βT + γG+ θTG+ u.
Therefore, estimation of B− is fairly straightforward.
The first lower and upper bounds, i.e. E(Yt1,gt |D = 1)−M and E(Yt1,gt |D = 1)−m, arise
from boundedness of Y (0) alone, while
DIDY 0−
P(Dt1,gt = 1)
and
DIDY 0+
P(Dt1,gt = 1)
arise from the combination of boundedness and common trend. When B− = E(Yt1,gt |D =
1) −M and B+ = E(Yt1,gt |D = 1) −m, the bounds are uninformative: common trend does
not add any supplementary information on ATTt1,gt to the information we can derive from
the mere fact that Y (0) is bounded. It is easy to show that if PAT ≤ P(Dt1,gt = 1), that is
to say if the share of treated observations in the (t1; gt) cell is greater than the sum of the
shares of always takers, then at least one of the bounds is informative. Conversely, when
PAT > P(Dt1,gt = 1), at least one of the bounds is uninformative.
When
B− =
DIDY 0−
P(Dt1,gt = 1)
10
and
B+ =
DIDY 0+
P(Dt1,gt = 1)
,
the length of [B−;B+] is equal to
(M −m)× PAT
P(Dt1,gt = 1)
.
Therefore, the two bounds will be tight when PATP(Dt1,gt=1) is small, that is to say when there
are "few" always takers with respect to treated observations in the (t1; gt) cell.
I illustrate what "few" always takers means through a numerical example. I consider
a binary outcome Y , such that DIDY = 0.05: the mean of Y increased by 5 percentage
points more in the treatment than in the control group from period 0 to 1. To simplify the
discussion, I assume that P(Dt0,gt = 1) = P(Dt0,gc = 1) = 0, so that PAT = P(Dt1,gc = 1).
This corresponds for instance to applications considering an innovation released in period 1 so
that no observation is treated in period 0 in the treatment and in the control groups. Finally,
I assume that P(Dt1,gt = 1) = 0.5 and E(Yt1,gc |D = 1) = 0.6. Under those assumptions, I
can write B− and B+ as functions of P(Dt1,gc = 1), the share of treated observations in the
control group in period 1. Results are summarized in Table 1.
Table 1: Value of B− and B+ according to P(Dt1,gc = 1)
P(Dt1,gc = 1) 0% 2.5% 5% 7.5% 10% 12.5% 15% 17.5% 20%
B− 10% 8% 6% 4% 2% 0% -2% -4% -6%
B+ 10% 13% 16% 19% 22% 25% 28% 31% 34%
The length of [B−;B+] linearly increases with P(Dt1,gc = 1), from 0% at P(Dt1,gc = 1) = 0,
to 40% at P(Dt1,gc = 1) = 0.2. The sign of ATTt1,gt is identified as long as P(Dt1,gc = 1) is
below 12.5%.
Then, I show in Theorem 2.3 that it is possible to derive tighter bounds under the monotone
treatment response assumption considered by Manski (1997). Before stating Theorem 2.3, I
define the following random variables:
Y 1− = Y + (m− Y )ATt0,gc
and
Y 1+ = Y + (m− Y ) (ATt0,gt +ATt1,gc) .
Y 1− replaces Y by m for treated observations in the (t0; gc) cell, while Y 1+ replaces Y by m for
treated observations in the (t0; gt) and (t1; gc) cells.
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Theorem 2.3 Partial identification 2
Under A.1, if P(m ≤ Y (0) ≤ Y (1)) = 1 with m ∈ R,
B
′
− ≤ ATTt1,gt ≤ B
′
+,
with
B
′
− = max
(
0;
DIDY 1−
P(Dt1,gt = 1)
)
and
B
′
+ = min
(
E(Yt1,gt |D = 1)−m;
DIDY 1+
P(Dt1,gt = 1)
)
.
B
′
− and B
′
+ are sharp.
The monotone treatment response assumption under which I derive 2.3 states that the
effect of the treatment on the outcome is always positive.7 As emphasized in Manski (1997),
it might be credible in some economic contexts, such as the analysis of the supply of a good
which can be assumed to be an increasing function of its price. This assumption partly disposes
of the bounded support assumption which was requested in Theorem 2.2, since in Theorem
2.3 it is only requested that the support of Y (0) is bounded by below. Therefore, Theorem 2.3
applies for instance when Y are wages while Theorem 2.2 does not. B′− is obtained through
the exact same steps as B−, except that the monotonicity assumption allows me to use Y (1)
instead of M as an upper bound for always takers’ Y (0). Consequently,
[
B
′
−;B
′
+
]
is shorter
than [B−;B+]. I compute B
′
− and B
′
+ in the same numerical example as above to illustrate
to what extent the monotonicity assumption tightens the bounds. One can see in Table 2:[
B
′
−;B
′
+
]
is approximately twice smaller than [B−;B+].
Table 2: Value of B′− and B
′
+ according to P(Dt1,gc = 1)
P(Dt1,gc = 1) 0% 2.5% 5% 7.5% 10% 12.5% 15% 17.5% 20%
B
′
− 10% 10% 10% 10% 10% 10% 10% 10% 10%
B
′
+ 10% 13% 16% 19% 22% 25% 28% 31% 34%
Finally, it is possible to derive bounds tighter than those obtained in Theorem 2.2 under
the assumption that the effect of the treatment does not change between period 0 and 1 in
the control group.8 Before stating Theorem 2.4, I introduce new notations.
7One could also derive another partial identification result under the alternative assumption that the effect
of the treatment is always negative.
8I am very grateful to Roland Rathelot for suggesting this result.
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Let 1{t1} (resp. 1{t0}) be an indicator equal to 1 when P(Dt0,gc = 1) < P(Dt1,gc = 1) (resp.
P(Dt0,gc = 1) > P(Dt1,gc = 1)). Let ∆E = E(Yt1,gc |D = 1)− E(Yt0,gc |D = 1). Let
Y 2− = Y +ATt0,gt(M − Y )
+ATt1,gc
(
1{t1} (min (M ;M + ∆E)− Y ) + 1{t0} (max (m;m+ ∆E)− Y )
)
+ATt0,gc
(
1{t1} (min (M ;M −∆E)− Y ) + 1{t0} (max (m;m−∆E)− Y )
)
and
Y 2+ = Y +ATt0,gt(m− Y )
+ATt1,gc
(
1{t1} (max (m;m+ ∆E)− Y ) + 1{t0} (min (M ;M + ∆E)− Y )
)
+ATt0,gc
(
1{t1} (max (m;m−∆E)− Y ) + 1{t0} (min (M ;M −∆E)− Y )
)
.
Theorem 2.4 Partial identification 3
Under A.1, if P(m ≤ Y (0) ≤M) = 1 with (m,M) ∈ R2, and ATTt1,gc = ATTt0,gc ,
B
′′
− ≤ ATTt1,gt ≤ B
′′
+,
with
B
′′
− = max
(
E(Yt1,gt |D = 1)−M ;
DIDY 2−
P(Dt1,gt = 1)
)
and
B
′′
+ = min
(
E(Yt1,gt |D = 1)−m;
DIDY 2+
P(Dt1,gt = 1)
)
B
′′
− and B
′′
+ are sharp.
As mentioned above, the common trend assumption can be rationalized by the following
DGP:
Y (d) = fd(T,U) + gd(G,U),
with U ⊥⊥ (T,G). In such a framework, ATTt1,gc = ATTt0,gc can be rationalized under two
supplementary assumptions: f0(t1, .)−f0(t0, .) = f1(t1, .)−f1(t0, .) and U ⊥⊥ T |G = gc, D = 1.
The first assumption means that the effect of time should be the same on Y (1) than on Y (0).
The second one means that treated observations in the control group should not be "too
different" in period 0 and 1. To assess the credibility of this last hypothesis, one can for
instance verify that those two groups of observations do not have very different observable
characteristics.
B
′′
− is obtained as follows. If ATTt1,gc = ATTt0,gc = ATTgc , (1) rewrites as
ATTt1,gt =
DIDY +ATTt0,gt × P(Dt0,gt = 1) +ATTgc (P(Dt1,gc = 1)− P(Dt0,gc = 1))
P(Dt1,gt = 1)
. (3)
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Moreover,
E (Yt1,gc −M |D = 1) ≤ ATTt1,gc ≤ E (Yt1,gc −m|D = 1)
and
E (Yt0,gc −M |D = 1) ≤ ATTt0,gc ≤ E (Yt0,gc −m|D = 1)
implies that
max (E (Yt1,gc |D = 1) ;E (Yt0,gc |D = 1))−M ≤ ATTgc ≤ min (E (Yt1,gc |D = 1) ;E (Yt0,gc |D = 1))−m.
Plugging this last inequality into (3) yields a first lower bound for ATTt1,gt . If P(Dt1,gc =
1) ≥ P(Dt0,gc = 1), one should use the left-hand side of the inequality, while if P(Dt1,gc = 1) <
P(Dt0,gc = 1), one should use the right-hand side. This first lower bound can be rewritten as
DIDY 2−
P(Dt1,gt = 1)
.
Finally, since ATTt1,gt is also greater than E(Yt1,gt |D = 1)−M , B
′′
− is defined as the maximum
of those two lower bounds.
From (3), one can see that the length of
[
B
′′
−;B
′′
+
]
essentially depends on
P(Dt0,gt = 1) + |P(Dt1,gc = 1)− P(Dt0,gc = 1)| .
Therefore,
[
B
′′
−;B
′′
+
]
will be shorter than [B−;B+] whose length is proportional to
P(Dt0,gt = 1) + P(Dt1,gc = 1) + P(Dt0,gc = 1).9
A situation in which those bounds will be tight is when the natural experiment under consider-
ation is the extension of a policy to a group previously not eligible, and the previously eligible
group is used as the control group. Indeed, in such cases P(Dt0,gt = 1) = 0. Consequently, if
the change in the treatment rate from period 0 to 1 in the control group is "small",
[
B
′′
−;B
′′
+
]
will be tight. Point identification can even be obtained if P(Dt1,gc = 1) = P(Dt0,gc = 1).
In such instances
[
B
′′
−;B
′′
+
]
improves a lot on [B−;B+] which will be wide as soon as the
percentage of observations treated in the control group is "large".
I illustrate what "small" and "large" mean through another numerical example. As above,
I consider a binary outcome Y , such that DIDY = 0.05. I assume that P(Dt0,gt = 1) = 0
and P(Dt1,gt = 1) = 0.5: this corresponds to the situation where the treatment group was not
eligible for treatment in period 0. I also assume that P(Dt0,gc = 1) = 0.4: 40% of the control
9This change in the size of the identification region is similar to the change happening when using Lee
bounds (see Lee (2009) and Horowitz & Manski (1995)) instead of Manski bounds (see Manski (1990)) to deal
with missing data.
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group was treated in period 0. Finally, I assume that E(Yt1,gc |D = 1) = E(Yt0,gc |D = 1) = 0.6.
Under those assumptions, I can write B−, B+, B
′′
− and B
′′
+ as functions of P(Dt1,gc = 1), the
share of treated observations in the control group in period 1. Results are summarized in
Table 3.
Table 3: Value of B−, B+, B
′′
− and B
′′
+ according to P(Dt1,gc = 1)
P(Dt1,gc = 1) 30% 32.5% 35% 37.5% 40% 42.5% 45% 47.5% 50%
B− -40% -40% -40% -40% -40% -40% -40% -40% -40%
B+ 60% 60% 60% 60% 60% 60% 60% 60% 60%
B
′′
− -2% 1% 4% 7% 10% 8% 6% 4% 2%
B
′′
+ 18% 16% 14% 12% 10% 13% 16% 19% 22%
Because of the large shares of treated observations in the control group, B− and B+ are
not informative: B− is merely equal to E(Yt1,gt |D = 1) −M = 0.6 − 1 = −0.4 and B+ to
E(Yt1,gt |D = 1) − m = 0.6. On the contrary, B
′′
− and B
′′
+ are informative. The length of[
B
′′
−;B
′′
+
]
is proportional to |P(Dt1,gc = 1)− P(Dt0,gc = 1)|. In this particular example, the
sign of ATTt1,gt is identified as long as the treatment rate does not change by more than 10
percentage points in the control group, which is substantial.
Finally, estimation of B′′− and B
′′
+ requires estimating P(Dt0,gc = 1), P(Dt1,gc = 1),
E(Yt1,gc |D = 1) and E(Yt0,gc |D = 1) in a first stage, before conducting the simple OLS
regression presented above on Y 2− and Y 2+.
A.1 is a strong identifying assumption which might appear implausible if pre-treatment
characteristics that are thought to be associated to the dynamics of the outcome variable are
unbalanced between the treatment and the control groups as emphasized in Abadie (2005). In
such instances, a conditional common trend assumption might appear more credible. When
compliance is perfect, Abadie shows that a standard DID still identifies an ATT under a
conditional common trend assumption, except that control group observations should be pre-
multiplied by a function wX , with
wX =
P(G = gt|X)
P(G = gc|X) ×
P(G = gt)
P(G = gc)
.
Therefore, the control scheme developed by Abadie works by weighting-down observations
in the control group for those values of the covariates which are over-represented among the
control group, and weighting-up those for those values of the covariates under-represented
among the control group, exactly as in a propensity score matching (see Rosenbaum & Rubin,
1983).
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All the results presented above can be extended under a conditional common trend as-
sumption. Indeed, I develop fuzzy semi-parametric DID results inspired from Abadie (2005)
which allow to control semi-parametrically for covariates. Most of those results merely require
to premultiply control group observations by the function wX and then to conduct the same
analysis as above, exactly as in Abadie (2005). Only the extension of Theorem 2.4 is more
involved. Therefore, I only present this result here, all the other results are to be found in the
appendix.
I introduce two new assumptions taken from Abadie (2005).
A.1’ Conditional common trend
With probability one,
E(Yt1,gt(0)|X)− E(Yt0,gt(0)|X) = E(Yt1,gc(0)|X)− E(Yt0,gc(0)|X)
A.2 Data
The data is either a panel, or consists of two random samples of the same population at dates
t0 and t1 such that at each date Y , D and G are observed, and covariates X at date t0 are
observed for both samples.
A.2 means that even when pooled cross sections are used in the analysis, covariates should
be observed in period 0 both for the period 0 and for the period 1 samples. As discussed
below, this might be an issue for time-varying covariates when pooled-crossed sections are
used.
I also introduce new notations. For any random variable Z, let
DIDXZ = E(Zt1,gt |X)− E(Zt0,gt |X)− [E(Zt1,gc |X)− E(Zt0,gc |X)]
be the DID on Z conditional on X. Let
ATTXi,j = E(Yi,j(1)− Yi,j(0)|D = 1, X), ∀(i, j) ∈ {t0; t1} × {gc; gt}
be the effect of the treatment on Y conditional on X among treated observations in the (i; j)
cell. For a random variable Z, let
WDIDZ = E(Zt1,gt)− E(Zt0,gt)−
[
E(Zt1,gcwX)− E(Zt0,gcwX)
]
be a DID on Z in which control group observations are given a weight wX . Let
pX =
P(Dt0,gc = 1|X)
P(Dt1,gc = 1|X)
.
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pX is greater than one for control group observations which, conditional on their covariates,
have a greater probability of being treated in period 0 than in period 1, and conversely. Let
Y 3− = Y + (M − Y )ATt0,gt + max
(
(M − Y ) (1− pX) ; (m− Y ) (1− pX))ATt1,gc ,
Y 3+ = Y + (m− Y )ATt0,gt + min
(
(M − Y ) (1− pX) ; (m− Y ) (1− pX))ATt1,gc ,
Y 4− = Y + (M − Y )ATt0,gt + min
(
(M − Y )
(
1− 1
pX
)
; (m− Y )
(
1− 1
pX
))
ATt0,gc
and
Y 4+ = Y + (m− Y )ATt0,gt + max
(
(M − Y )
(
1− 1
pX
)
; (m− Y )
(
1− 1
pX
))
ATt0,gc .
Before stating the result, I must first state a lemma.
Lemma 2.2 Conditional non-identification
Under A.1’,
DIDXY = ATT
X
t1,gt × P(Dt1,gt = 1|X)−ATTXt0,gt × P(Dt0,gt = 1|X)
−ATTXt1,gc × P(Dt1,gc = 1|X) +ATTXt0,gc × P(Dt0,gc = 1|X)
(4)
with probability one.
Lemma 2.2 is merely a conditional version of Lemma 2.1. It states that under A.1’, DIDXY
can be rewritten as a weighted DID of four conditionals ATT. From Lemma 2.2, one can show
Theorem 2.5.
Theorem 2.5 Conditional partial identification
Under A.1’ and A.2, if P(m ≤ Y (0) ≤ M) = 1 with (m,M) ∈ R2, ATTXt1,gc = ATTXt0,gc with
probability one, and P(Dt1,gc = 1|X) > 0⇔ P(Dt0,gc = 1|X) > 0 with probability one, then
WB
′′
− ≤ ATTt1,gt ≤WB
′′
+,
with
WB
′′
− = max
(
E(Yt1,gt |D = 1)−M ;
WDIDY 3−
P(Dt1,gt = 1)
;
WDIDY 4−
P(Dt1,gt = 1)
)
and
WB
′′
+ = min
(
E(Yt1,gt |D = 1)−m;
WDIDY 3+
P(Dt1,gt = 1)
;
WDIDY 4+
P(Dt1,gt = 1)
)
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WB
′′
− is obtained as follows. A mere integration over the distribution of X yields
ATTt1,gt =
∫
ATTXt1,gtdP (X|Dt1,gt = 1). (5)
From Lemma 2.2 one gets that
ATTXt1,gt =
DIDXY +ATT
X
t0,gt
× P(Dt0,gt = 1|X) +ATTXt1,gc × P(Dt1,gc = 1|X)−ATTXt0,gc × P(Dt0,gc = 1|X)
P(Dt1,gt = 1|X)
. (6)
If ATTXt1,gc = ATT
X
t0,gc , (6) rewrites both as
ATTXt1,gt =
DIDXY +ATT
X
t0,gt
× P(Dt0,gt = 1|X) +ATTXt1,gc × (P(Dt1,gc = 1|X)− P(Dt0,gc = 1|X))
P(Dt1,gt = 1|X)
(7)
and
ATTXt1,gt =
DIDXY +ATT
X
t0,gt
× P(Dt0,gt = 1|X) +ATTXt0,gc × (P(Dt1,gc = 1|X)− P(Dt0,gc = 1|X))
P(Dt1,gt = 1|X)
. (8)
Therefore, to derive a first lower bound for ATTt1,gt , I start bounding ATTXt1,gc by
E (Yt1,gc −M |D = 1, X) when P(Dt1,gc = 1|X) ≥ P(Dt0,gc = 1|X) and by E (Yt1,gc −m|D = 1, X)
when P(Dt1,gc = 1|X) < P(Dt0,gc = 1|X) in (7). This yields a bound for ATTXt1,gt which I
plug into (5). Then I use Bayes rule to write this bound as a quantity which can be easily
estimated from the sample since it is equal to
WDIDY 3−
P(Dt1,gt = 1)
.
Following the same steps, I derive a second lower bound for ATTt1,gt using (8), which is equal
to
WDIDY 4−
P(Dt1,gt = 1)
.
Finally, since ATTt1,gt is also greater than E(Yt1,gt |D = 1) − M , WB
′′
− is defined as the
maximum of those three lower bounds.
Those fuzzy semi-parametric DID results improve on the fuzzy DID results on two dimen-
sions. First, conditional common trend is more credible than common trend in many contexts
as emphasized above. Moreover, Theorem 2.5 no longer requires that ATTt1,gc = ATTt0,gc
but that ATTXt1,gc = ATT
X
t0,gc . This is probably a more credible assumption, all the more so if
observable characteristics of treated observations in the control group change between period
0 and 1.
The main limitation of those fuzzy semi-parametric DID results is that they require that
covariates are observed in period 0 both for the period 0 and for the period 1 samples, exactly
as for Abadie’s semi-parametric DID results. This might raise a data availability issue for
time-varying covariates when pooled-crossed sections are used. In such instances, since all
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the parameters identified above can be estimated through simple linear regressions, another
option to control for covariates could merely be to include them in those regressions. For
instance, one could run the following regression
Y 0− = α+ βT + γG+ δX + µXT + θTG+ u, (9)
to estimateDIDY 0− taking into account the effect of covariates on the dynamics of the outcome.
The main limit of this second approach is that, as emphasized in Meyer (1995), introducing
covariates in this linear fashion may not be appropriate if the treatment has different effects
for different groups in the population.
3 Inference
The objective of this section is to build up confidence intervals (CI) for ATTt1,gt based upon
the results of section 2. Deriving such confidence intervals from the point identification results
is straightforward: one can use the delta method to derive the asymptotic distribution of
D̂IDY
D̂IDD
. Using partial identification results proves less straightforward. An extensive literature
on confidence intervals for partially identified parameters developed recently. Some solutions
have been proposed by Imbens & Manski (2004) and Stoye (2009) but they do not apply here.
Indeed, they require uniform asymptotic normality of the estimators. As shown in Hirano &
Porter (2009), there exists no regular estimators of parameters defined as non continuously
differentiable functional of the data distribution. B− and B+, just as all the other bounds
presented in section 2, are not continuously differentiable functionals of the data distribution.
Indeed,
B− = max
(
E(Yt1,gt |D = 1)−M ;
DIDY 0−
P(Dt1,gt = 1)
)
for instance.
Therefore, I use a recent method from the moment inequality literature, developed by
Andrews & Soares (2010) which applies to my setting and does not require this regularity
condition.10
Let θ0 = ATTt1,gt be my parameter of interest and F0 be the true distribution of the data.
10Chernozhukov et al. (2011) does not apply here because my bounds are not intersection bounds.
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When m ≤ Y (0) ≤M , Theorem 2.2 implies that θ0 verifies four inequalities:
θ0 −B1 ≥ 0
θ0 −B2 ≥ 0
B3 − θ0 ≥ 0
B4 − θ0 ≥ 0,
(10)
with B1 =
DID
Y 0−
P(Dt1,gt=1)
, B2 = E(Yt1,gt−M |D = 1), B3 =
DID
Y 0+
P(Dt1,gt=1)
and B4 = E(Yt1,gt−m|D =
1). The set of all (θ, F ) compatible with those moment inequalities is denoted F .
Let
Tn (θ) =
2∑
j=1
[
√
n
θ − B̂j
σ̂j
]2− +
4∑
j=3
[
√
n
B̂j − θ
σ̂j
]2−,
where [x]− = x if x < 0 and 0 otherwise and where σj is the asymptotic variance of√
n
(
Bj − B̂j
)
. Let Dj be an indicator variable equal to 1 when
√
n θ0−B̂jσ̂j ≤
√
2 ln(ln(n)) for
j = 1 or 2, and when
√
n B̂
j−θ0
σ̂j
≤ √2 ln(ln(n)) for j = 3 or 4. Let CSn be the confidence
interval obtained inverting Tn (θ), using as critical values c1−α(θ) the (1−α)th quantile of the
distribution of ∑
1≤j≤4/Dj=1
[N j ]2−,
where
(
N1, N2, N3, N4
)′
is a vector of N (0, 1) random variables with a variance Ω equal to
the asymptotic variance of
√
n
(
B1 − B̂1
σ̂1
,
B2 − B̂2
σ̂2
,
B̂3 −B3
σ̂3
,
B̂4 −B4
σ̂4
)′
.
Formally,
CSn = {θ / Tn(θ) ≤ c1−α(θ)}.
Theorem 3.1 Inference
When m ≤ Y (0) ≤ M , if m′ ≤ Y (1) ≤ M ′ with (m′,M ′) ∈ R2 and if there exists  > 0 such
that P (T = i, G = j) ≥ , for every (i, j) ∈ {t0; t1}×{gc; gt}, then CSn is uniformly valid and
not conservative:
lim inf
n→+∞ inf(θ,F )∈F
PF (Tn(θ) ≤ c1−α(θ)) = 1− α.
The proof of Theorem 3.1 essentially amounts to show that assumptions of the inequality
model developed by Andrews & Soares (2010) hold here. In order to do so, I take a few more
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assumptions than in Theorem 2.2. The assumption that Y (1) also is bounded is not very
restrictive: it is hard to envision real life situations where Y (0) is bounded but not Y (1). The
assumption that there exists  > 0 such that P (T = i, G = j) ≥  is just to rule out degenerate
probability distributions. Since all the inequalities are linear in θ0, inverting the test is fairly
simple.
The intuition of this result is as follows. For j = 1 or 2, if θ0 > Bj ,
lim
n→+∞
√
n
θ0 − B̂j
σ̂j
= +∞
with probability one. Similarly, for j = 3 or 4, if Bj > θ0,
lim
n→+∞
√
n
B̂j − θ0
σ̂j
= +∞.
Therefore, Tn (θ0) converges in distribution towards∑
1≤j≤4/θ0=Bj
[N j ]2−.
Consequently, the limiting distribution of the test statistic and the critical values to be used
when inverting it would be known if we knew which inequalities are actually equalities. To solve
this problem, Andrews & Soares (2010) introduce the following decision rule: they consider an
inequality as an equality when
√
n θ0−B̂jσ̂j ≤
√
2 ln(ln(n)) (or when
√
n θ0−B̂jσ̂j ≤
√
2 ln(ln(n))
for j = 3 or 4) , i.e. when
√
n θ0−B̂jσ̂j is not "too large". The reason why the resulting CI
is uniformly valid is that when θ0 = Bj ,
√
n θ0−B̂jσ̂j converges to a N (0, 1) random variable.
Since
√
2 ln(ln(n)) converges to +∞, the probability to wrongly consider an equality as an
inequality vanishes to 0.
Finally, Theorems 2.3 and 2.4 can also be written as moment inequality models. Therefore,
it is also possible to derive CI for θ0 from B̂
′
− and B̂
′
+, or from B̂
′′
− and B̂
′′
+, using the method
of Andrews & Soares (2010). Since Theorem 2.3 does not require that Y is bounded, when
B̂
′
− and B̂
′
+ are used to construct a CI for θ0, one will have to add the technical assumption
that EF
(
|Y (d)|2+δ
)
< K for d = 0 or 1, where K is a constant and δ > 0.
4 The impact of varenicline on smoking cessation.
4.1 Data and methods
The national data base of French smoking cessation clinics started in 2001. 59 clinics recorded
at least one patient per year in 2006 and 2007. During patients first visit, smoking status
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is evaluated according to daily cigarettes smoked and a measure of expired carbon monoxide
(CO) which is a biomarker for recent tobacco use. At the end of this baseline visit, treatments
may be prescribed to patients (nicotine replacement therapies. . . ). Follow-up visits are offered
during which CO measures are usually made to check whether the patient remained abstinent.
Varenicline is a pharmacotherapy for smoking cessation support which was made available
to these clinics in February 2007. The kernel density estimate of the rate of prescription of
varenicline per clinic is shown in Figure 1. It is bimodal, with a first peak at very low rates
of prescription, and a second smaller peak around 35-40%. In 15 clinics, less than 3% of all
patients consulted have been prescribed varenicline during the year following its release. In
13 clinics, more than 20% of patients have received this new drug. I exploit this to estimate
the impact of varenicline on smoking cessation. The control group is made up of patients
registered by the 15 "below 3% prescription rate" clinics, hereafter referred to as the control
clinics. The treatment group consists of patients recorded by "above 20% prescription rate"
clinics, hereafter referred to as treatment clinics. Period 0 goes from February 2006 to January
2007, and period 1 from February 2007 to January 2008.
0
2
4
6
0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50
Density of the rate of prescription of varenicline
Figure 1: Density of the prescription rate of Varenicline across clinics.
8 581 patients consulted those 28 clinics over period 0 and 1. Because many patients never
came back for follow-up visits, there are only 5 299 patients (62% of the initial sample) for
whom follow-up CO measures are available. I exclude patients for whom no such measures
are available from the analysis. Among remaining patients, the outcome variable is a dummy
equal to 1 for patients whose last follow-up CO determination was inferior or equal to 5 parts
per million (ppm).
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4.2 Results
In Table 4, I provide descriptive statistics on patients per group of clinics and per period of
time. Patients consulted in those cessation clinics are middle-aged, rather educated and the
majority of them are employed. They are very heavy smokers since they smoke more than
21.6 cigarettes per day on average, which corresponds to the 90th percentile in the French
distribution of smokers (Beck et al. (2007)).
Table 4: Descriptive Statistics
Treatment Clinics Control Clinics
2006 2007 P-value 2006 2007 P-value
Patients’ characteristics
% Males 47.9% 47.9% 0.95 48.5% 50.4% 0.30
Age 44.6 43.7 0.08 44.0 44.3 0.52
% employed 65.3% 68.3% 0.11 65.3% 69.8% 0.01
% without degree 19.2% 21.0% 0.25 14.2% 14.1% 0.98
Daily cigarettes smoked 21.7 21.9 0.6 22.1 20.9 <0.01
Treatment prescribed
% prescribed nicotine patch 75.0% 45.5% <0.001 45.9% 49.7% 0.05
% prescribed varenicline 0.01% 38.2% <0.001 0% 1.6% <0.001
% of successful quits 53.7% 56.9% 0.11 46.6% 41.6% <0.01
N 1 195 1 303 1 300 1 501
In period 0, the prescription rate of varenicline was equal to 0% in control clinics and to
0.01% in treatment clinics.11 In period 1, it rose to 1.6% in control clinics and to 38.2% in
treatment clinics. This sharp rise in varenicline prescription in treatment clinics entailed a
strong decrease in the prescription of other treatments such as nicotine patch. Finally, from
period 0 to 1, abstinence rate increased (from 53.7% to 56.9%) in treatment clinics, whereas
it decreased (from 46.6% to 41.6%) in control clinics.
From Theorem 2.2, I compute that B̂− = 19.1% and B̂+ = 24.5%. Using Theorem 3.1,
I find that [0.074; 0.364] is a 95% confidence interval for ATTt1,gt . Some covariates are not
balanced across treatment and control patients. For instance, patients in treatment clinics
are less educated. If those covariates also have an impact on the dynamic of the outcome,
the common trend assumption might be violated, hence the need to control for them. Many
covariates available in the data are time varying, such as daily cigarettes smoked. Therefore,
I cannot use the semi-parametric fuzzy DID results of section 2. Instead, I merely estimate
DIDY 0− including controls (sex, age, employment status, daily cigarettes smoked and CO at
11Varenicline was prescribed to 6 patients recorded in the last week of January 2007, that is to say a few
days before its release.
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baseline) into the regression as in equation (9). This results in a slight change of B̂− which
increases to 22.9%. B̂+ also slightly increases.
4.3 Robustness checks
The main assumption needed to identify [B−; B+] is the common trend assumption. To
indirectly assess its validity, I use the fact that I have several years of data available and I
compute placebo DID from 2003 to 2008. They are displayed in Table 5 along with their
P-values. Only the 2006-2007 DID is significant. This means that 2006 and 2007 are the only
two years between which the cessation rate did not follow parallel trends in the two groups of
clinics. Between 2003 and 2004, 2004 and 2005, 2005 and 2006, and 2007 and 2008, trends in
cessation rates were not significantly different in the two groups of clinics. The common trend
assumption states that the cessation rate would have followed parallel trends between 2006
and 2007 if varenicline had not been released. The fact that before and after the release of
varenicline, cessation rate indeed followed roughly parallel trends in the two groups of clinics
gives some credit to that assumption.
Attrition seems orthogonal to the interaction of period 1 and treatment clinics, since the
DID computed on the percentage of patients included is low and insignificant (+2.2%, P-value
= 0.62). Therefore, estimates do not seem contaminated by attrition bias.
Table 5: Placebo DID
Placebo DID P-value N
On cessation rate
2003-2004 0.045 0.34 1 580
2004-2005 0.032 0.53 2 499
2005-2006 0.042 0.31 4 136
2006-2007 0.082 0.01 5 299
2007-2008 -0.043 0.46 4 400
On attrition rate
2006-2007 0.022 0.62 8 581
Note: Standard errors are clustered at the clinic level.
Finally, one might worry about the arbitrariness of the definition of my treatment and
control groups which is not based on some objective characteristic of cessation clinics. I
investigate the sensitivity of the results to the 3%-20% rule as a robustness check. Here, since
there are very few always takers, B− = B1. I run the same analysis with 9 different pairs of
thresholds, which makes the sample of clinics included vary from 18 to 38. As shown in Table
6, I always get B̂1 ≥ 0, with 5 P-values lower than 0.10. Results are less significant when the
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threshold used for control clinics is a prescription rate of 4%. Firstly, this is not necessarily
surprising since the bounds are less tight when there are more always takers. Moreover, those
results become significant again when controls are included.
Table 6: P-value of B̂1 according to inclusion thresholds
Treatment threshold: 15% Treatment threshold: 20% Treatment threshold: 25%
Control threshold: 2% 0.10 0.08 0.14
Control threshold: 3% 0.03 0.02 0.06
Control threshold: 4% 0.20 0.15 0.27
Note: Standard errors are clustered at the clinic level.
4.4 Why do treatment and control clinics have different prescription rates
?
Finally, I tentatively investigate where the difference in varenicline prescription rates across
clinics comes from. It might merely come from the fact patients coming to those two groups
of clinics are different and need different drugs. A simple probit regression of varenicline pre-
scription indicates that it is positively related to patients employment status, daily cigarettes
smoked and addiction levels. However, treatment and control patients consulted in period 1
significantly differ only on cigarettes smoked (1 more cigarette smoked per day in treatment
clinics).
A second hypothesis is that professionals working in those clinics differ, either in terms of
occupation, qualifications or beliefs about effective ways of accompanying smoking cessation.
Information on professionals working in smoking cessations clinics is available for only 7 clinics
(4 treatment and 3 control) out of the 28 included in the analysis. Still, the 4 treatment clinics
recorded 1 612 patients over period 0 and 1, that is to say 64.5% of the "treatment" sample,
and the 3 control clinics recorded 1 828 patients, that is to say 65.3% of the control sample. It
appears that within this subsample of the total population, treatment patients had a higher
probability of being consulted by a doctor (76% against 47%). On the contrary, they had a
lower probability of being consulted by a psychologist (3% against 18%) or by someone trained
to behavioral and cognitive therapies (4% against 48%). Finally, treatment clinics consulted
193 new patients per full time working professional in 2007, against only 75 in control clinics.
Contrarily to nicotine replacement therapies, varenicline must be prescribed by a doctor.
The sharp difference in prescription rates across the two groups of clinics might therefore come
from the lower proportion of doctors in control clinics. But patients consulted in those clinics
still had a 47% probability of being consulted by a doctor and only 1.6% were prescribed
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varenicline. A complementary explanation is that there might be two approaches to smoking
cessation among professionals. The first approach, which seems more prominent in treatment
clinics, puts the emphasis on providing patients pharmacotherapies to reduce the symptoms
of withdrawal. The second approach, which seems more prominent in control clinics, lays
more the emphasis on giving them intensive psychological support, hence the higher share
of professionals trained to behavioral and cognitive therapies, the lower number of patients
consulted per professional and the lower prescription rate of nicotine patches previous to the
release of varenicline.
5 Conclusion
This paper develops new results to identify treatment effects when the treatment rate increases
more in one group between two periods. The parameters identified will be informative in
applications with no or few always takers, as well as in applications where the treatment rate
does not change much between the two periods in the control group. My results essentially
hold under a common trend assumption on the outcome, whereas the IV-DID result commonly
invoked in such settings holds under two common trends assumptions on the outcome and on
the treatment, and under a monotonicity assumption. I give examples of applications in which
it might be appealing to dispose of the common trend assumption on D while maintaining it
on Y .
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Appendix A: Identification under conditional common trend
Theorem 5.1 Conditional identification
1. Under A.1’ and A.2, in the no always takers special case,
ATTt1,gt =
WDIDY
P(Dt1,gt = 1)
2. Under A.1’ and A.2, if P(m ≤ Y (0) ≤M) = 1 with (m,M) ∈ R2,
WB− ≤ ATTt1,gt ≤WB+,
with
WB− = max
(
E(Yt1,gt |D = 1)−M ;
WDIDY 0−
P(Dt1,gt = 1)
)
and
WB+ = min
(
E(Yt1,gt |D = 1)−m;
WDIDY 0+
P(Dt1,gt = 1)
)
.
3. Under A.1’ and A.2, if P(m ≤ Y (0) ≤ Y (1)) = 1 with m ∈ R,
WB
′
− ≤ ATTt1,gt ≤WB
′
+,
with
WB
′
− = max
(
0;
WDIDY 1−
P(Dt1,gt = 1)
)
and
WB
′
+ = min
(
E(Yt1,gt |D = 1)−m;
WDIDY 1+
P(Dt1,gt = 1)
)
.
Points 1 to 3 of Theorem 5.1 are obtained as follows. Plugging (6) into (5) and using Bayes
rule yields
ATTt1,gt =
WDIDY +ATTt0,gt×P(Dt0,gt=1)+WATTt1,gc×P(Dt1,gc=1)−WATTt0,gc×P(Dt0,gc=1)
P(Dt1,gt=1)
, (11)
where WATTi,gc = E
(
(Yi,j(1)− Yi,j(0))wX |D = 1
)
, for i ∈ {t0; t1}, are weighted ATTs in
the two control group cells, in which observations are given a weight wX . In the no always
takers case, P(Dt0,gt = 1) = P(Dt1,gc = 1) = P(Dt0,gc = 1) = 0, hence the first claim. Then, if
m ≤ Y (0) ≤ M , ATTt0,gt , WATTt1,gc and WATTt0,gc can all be bounded, hence the second
claim. Finally, if m ≤ Y (0) ≤ Y (1), I can use this inequality to derive new bounds for
ATTt0,gt , WATTt1,gc and WATTt0,gc , hence the third claim.
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Appendix B: Proofs
Proof of Lemma 2.1:
Y = Y (1)×D + Y (0)× (1−D) = (Y (1)− Y (0))×D + Y (0).
Therefore,
DIDY = E [(Yt1,gt(1)− Yt1,gt(0))D]− E [(Yt0,gt(1)− Yt0,gt(0))D]
−E [(Yt1,gc(1)− Yt1,gc(0))D] + E [(Yt0,gc(1)− Yt0,gc(0))D]
+E(Yt1,gt(0))− E(Yt0,gt(0))− E(Yt1,gc(0)) + E(Yt0,gc(0)).
Under A.1,
E(Yt1,gt(0))− E(Yt0,gt(0))− E(Yt1,gc(0)) + E(Yt0,gc(0)) = 0.
Thus,
DIDY = E(Yt1,gt(1)− Yt1,gt(0)|D = 1)× P(Dt1,gt = 1)
−E(Yt0,gt(1)− Yt0,gt(0)|D = 1)× P(Dt0,gt = 1)
−E(Yt1,gc(1)− Yt1,gc(0)|D = 1)× P(Dt1,gc = 1)
+E(Yt0,gc(1)− Yt0,gc(0)|D = 1)× P(Dt0,gc = 1),
hence the result.
QED.
Proof of Theorem 2.1:
Proof of 1)
In the “no always takers” special case, P(Dt0,gt = 1), P(Dt1,gc = 1) and P(Dt0,gc = 1) are all
equal to 0. Therefore, (1) can be rewritten as
DIDY = ATTt1,gt × P(Dt1,gt = 1)
hence the result.
Proof of 2)
If ∀(i, j) ∈ {t0; t1} × {gc; gt} , ATTi,j = ATTt1,gt , then, (1) can be rewritten as
DIDY = ATTt1,gt ×DIDD,
hence the result.
QED.
Proof of Theorem 2.2:
Let
A = E(Yt0,gt(0)|D = 1)×P(Dt0,gt = 1)+E(Yt1,gc(0)|D = 1)×P(Dt1,gc = 1)−E(Yt0,gc(0)|D = 1)×P(Dt0,gc = 1).
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This is the only quantity appearing in (2) which cannot be estimated from the sample and
therefore needs to be bounded.
Since m ≤ Y (0) ≤M ,
A−1 ≤ A ≤ A+1 ,
with
A−1 = m× P(Dt0,gt = 1) +m× P(Dt1,gc = 1)−M × P(Dt0,gc = 1)
and
A+1 = M × P(Dt0,gt = 1) +M × P(Dt1,gc = 1)−m× P(Dt0,gc = 1).
For bounds to be sharp, a DGP attaining them should also verify the common trend assump-
tion, which implies:
0 = E(Yt1,gt(0)|D = 1)× P(Dt1,gt = 1) + E(Yt1,gt |D = 0)× (1− P(Dt1,gt = 1))
−E(Yt0,gt(0)|D = 1)× P(Dt0,gt = 1)− E(Yt0,gt |D = 0)× (1− P(Dt0,gt = 1))
−E(Yt1,gc(0)|D = 1)× P(Dt1,gc = 1)− E(Yt1,gc |D = 0)× (1− P(Dt1,gc = 1))
+E(Yt0,gc(0)|D = 1)× P(Dt0,gc = 1) + E(Yt0,gc |D = 0)× (1− P(Dt0,gc = 1)).
The only quantity in this equation which is both unobserved and does not enter into (2) is
E(Yt1,gt(0)|D = 1). For common trend to hold, it should be equal to
1
P(Dt1,gt=1)
(A+ E(Yt0,gt |D = 0)× (1− P(Dt0,gt = 1)) + E(Yt1,gc |D = 0)× (1− P(Dt1,gc = 1)))
− 1P(Dt1,gt=1) (E(Yt1,gt |D = 0)× (1− P(Dt1,gt = 1)) + E(Yt0,gc |D = 0)× (1− P(Dt0,gc = 1))) .
Since m ≤ E(Yt1,gt(0)|D = 1) ≤M , this implies that
A−2 ≤ A ≤ A+2 ,
with
A−2 = m× P(Dt1,gt = 1)− E(Yt0,gt |D = 0)× (1− P(Dt0,gt = 1))
−E(Yt1,gc |D = 0)× (1− P(Dt1,gc = 1)) + E(Yt1,gt |D = 0)× (1− P(Dt1,gt = 1))
+E(Yt0,gc |D = 0)× (1− P(Dt0,gc = 1)).
and
A+2 = M × P(Dt1,gt = 1)− E(Yt0,gt |D = 0)× (1− P(Dt0,gt = 1))
−E(Yt1,gc |D = 0)× (1− P(Dt1,gc = 1)) + E(Yt1,gt |D = 0)× (1− P(Dt1,gt = 1))
+E(Yt0,gc |D = 0)× (1− P(Dt0,gc = 1)).
Consequently,
max(A−1 ;A
−
2 ) ≤ A ≤ min(A+1 ;A+2 ). (12)
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Combining (2) and (12) and rearranging yields B− and B+, which are sharp by construction.
QED.
Proof of Theorem 2.3:
Since m ≤ Y (0) ≤ Y (1),
A−3 ≤ A ≤ A+3 ,
with
A−3 = m× P(Dt0,gt = 1) +m× P(Dt1,gc = 1)− E(Yt0,gc |D = 1)× P(Dt0,gc = 1)
and
A+3 = E(Yt0,gt |D = 1)× P(Dt0,gt = 1) + E(Yt1,gc |D = 1)× P(Dt1,gc = 1)−m× P(Dt0,gc = 1).
For bounds to be sharp, a DGP attaining them should also verify the common trend assump-
tion. Given that m ≤ E(Yt1,gt(0)|D = 1) ≤ E(Yt1,gt |D = 1), this implies that
A−4 ≤ A ≤ A+4 ,
with
A−4 = A
−
2
and
A+4 = E(Yt1,gt |D = 1)× P(Dt1,gt = 1)− E(Yt0,gt |D = 0)× (1− P(Dt0,gt = 1))
−E(Yt1,gc |D = 0)× (1− P(Dt1,gc = 1)) + E(Yt1,gt |D = 0)× (1− P(Dt1,gt = 1))
+E(Yt0,gc |D = 0)× (1− P(Dt0,gc = 1)).
Consequently,
max(A−3 ;A
−
4 ) ≤ A ≤ min(A+3 ;A+4 ). (13)
Combining (2) and (13) and rearranging yields B′− and B
′
+, which are sharp by construction.
QED.
Proof of Theorem 2.4:
I prove the result for B′′+ only.
Let
C = ATTt0,gt × P(Dt0,gt = 1) +ATTt1,gc × P(Dt1,gc = 1)−ATTt0,gc × P(Dt0,gc = 1).
This is the only quantity appearing in (1) which cannot be estimated from the sample and
therefore needs to be bounded to bound ATTt1,gt .
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If ATTt1,gc = ATTt0,gc = ATTgc ,
C = ATTt0,gt × P(Dt0,gt = 1) +ATTgc (P(Dt1,gc = 1)− P(Dt0,gc = 1)) .
Therefore, when m ≤ Y (0) ≤M ,
C− ≤ C
with
C− = E(Yt0,gt −M |D = 1)× P(Dt0,gt = 1)
+1{t1} (max (E(Yt1,gc |D = 1);E(Yt0,gc |D = 1))−M) (P(Dt1,gc = 1)− P(Dt0,gc = 1))
+1{t0} (min (E(Yt1,gc |D = 1);E(Yt0,gc |D = 1))−m) (P(Dt1,gc = 1)− P(Dt0,gc = 1)) .
A DGP attaining C− will verify A = A+5 , with
A+5 = M × P(Dt0,gt = 1) +
(
1{t1}min (M ;M + ∆E) + 1{t0}max (m;m+ ∆E)
)× P(Dt1,gc = 1)
+
(
1{t1}min (M ;M −∆E) + 1{t0}max (m;m−∆E)
)× P(Dt0,gc = 1).
Since C is a decreasing function of A,
C− ≤ C ⇒ A ≤ A+5
But for bounds to be sharp, the DGP attaining them should also verify the common trend
assumption, which implies that
A ≤ A+2 .
Consequently,
A ≤ min(A+2 ;A+5 ). (14)
Combining (2) and (14) and rearranging yields B′′+, which is sharp by construction.
QED.
Proof of Lemma 2.2:
The proof is the same as the proof of Lemma 2.1, except that all expectations should be taken
conditional to X.
QED.
Proof of Theorem 5.1
I start proving equation (11). Let us rewrite ATTt1,gt . It is equal to∫
ATTXt1,gtdP (X|Dt1,gt = 1)
=
∫
DIDXY +ATT
X
t0,gt × P(Dt0,gt = 1|X) +ATTXt1,gc × P(Dt1,gc = 1|X)−ATTXt0,gc × P(Dt0,gc = 1|X)
P(Dt1,gt = 1|X)
dP (X|Dt1,gt = 1)
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=
1
P(Dt1,gt = 1)
∫
DIDXY +ATT
X
t0,gt × P(Dt0,gt = 1|X) +ATTXt1,gc × P(Dt1,gc = 1|X)dP (Xgt)
− 1
P(Dt1,gt = 1)
∫
ATTXt0,gc × P(Dt0,gc = 1|X)dP (Xgt)
=
1
P(Dt1,gt = 1)
∫
E(Yt1,gt |X)− E(Yt0,gt |X)− [E(Yt1,gc |X)− E(Yt0,gc |X)] dP (Xgt)
+
1
P(Dt1,gt = 1)
∫
ATTXt0,gt × P(Dt0,gt = 1|X) +ATTXt1,gc × P(Dt1,gc = 1|X)−ATTXt0,gc × P(Dt0,gc = 1|X)dP (Xgt)
=
1
P(Dt1,gt = 1)
[E(Yt1,gt)− E(Yt0,gt) + E ((Yt0,gt(1)− Yt0,gt(0))D)]−
1
P(Dt1,gt = 1)
∫
E(Yt1,gc |X)− E(Yt0,gc |X)dP (Xgt)
+
1
P(Dt1,gt = 1)
∫
ATTXt1,gc × P(Dt1,gc = 1|X)−ATTXt0,gc × P(Dt0,gc = 1|X)dP (Xgt)
=
1
P(Dt1,gt = 1)
[
E(Yt1,gt)− E(Yt0,gt)− E(Yt1,gcwX) + E(Yt0,gcwX)
]
+
1
P(Dt1,gt = 1)
[
ATTt0,gt × P(Dt0,gt = 1) + E
(
(Yt1,gc(1)− Yt1,gc(0))wXD
)
− E
(
(Yt1,gc(1)− Yt1,gc(0))wXD
)]
=
1
P(Dt1,gt = 1)
[WDIDY +ATTt0,gt × P(Dt0,gt = 1) +WATTt1,gc × P(Dt1,gc = 1)−WATTt0,gc × P(Dt0,gc = 1)] .
The first equality comes from Lemma 2.2 combined with the fact that the integral is taken over
the set of all ω such that P(Dt1,gt = 1|X)(ω) 6= 0. The second equality is obtained using the
definition of conditional probabilities, and using A.2 which implies that dP (Xt1,gt) = dP (Xgt).
Finally, the fifth equality is obtained using Bayes’ law.
Proof of 1)
In the “no always takers” special case, P(Dt0,gt = 1), P(Dt1,gc = 1) and P(Dt0,gc = 1) are all
equal to 0. Therefore, (11) rewrites
ATTt1,gt =
WDIDY
P(Dt1,gt = 1)
,
hence the result.
Proof of 2)
If m ≤ Y (0) ≤M , then
E(Yt0,gt −M |D = 1) ≤ ATTt0,gt ≤ E(Yt0,gt −m|D = 1),
E
(
(Yt1,gc −M)wX |D = 1
) ≤WATTt1,gc ≤ E ((Yt1,gc −M)wX |D = 1)
and
E
(
(Yt0,gc −M)wX |D = 1
) ≤WATTt0,gc ≤ E ((Yt0,gc −m)wX |D = 1) .
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Plugging those three inequalities into (11) yields
WDIDY 0−
P(Dt1,gt = 1)
≤ ATTt1,gt ≤
WDIDY 0+
P(Dt1,gt = 1)
,
hence the result.
Proof of 3)
If m ≤ Y (0) ≤ Y (1), then
0 ≤ ATTt0,gt ≤ E(Yt0,gt −m|D = 1),
0 ≤WATTt1,gc ≤ E
(
(Yt1,gc −M)wX |D = 1
)
and
0 ≤WATTt0,gc ≤ E
(
(Yt0,gc −m)wX |D = 1
)
.
Plugging those three inequalities into (11) yields
WDIDY 1−
P(Dt1,gt = 1)
≤ ATTt1,gt ≤
WDIDY 1+
P(Dt1,gt = 1)
,
hence the result.
QED.
Proof of Theorem 5.1
I only show how to derive WB′′−. Let
min(X) = min (m1(X);m2(X))
where
m1(X) = E(Yt1,gc −M |D = 1, X) (P(Dt1,gc = 1|X)− P(Dt0,gc = 1|X))
and
m2(X) = E(Yt1,gc −m|D = 1, X) (P(Dt1,gc = 1|X)− P(Dt0,gc = 1|X)) .
Let
Emin = E
(
min
(
(Yt1,gc −M)
(
1− pX) ; (Yt1,gc −m) (1− pX))wX |D = 1) .
Finally, let 1{t1}(X) and 1{t0}(X) be the indicators of the events P(Dt1,gc = 1|X) > P(Dt0,gc = 1|X)
and P(Dt1,gc = 1|X) < P(Dt0,gc = 1|X).
If ATTXt1,gc = ATT
X
t0,gc , (6) rewrites as
ATTXt1,gt =
DIDXY +ATT
X
t0,gt × P(Dt0,gt = 1|X) +ATTXt1,gc (P(Dt1,gc = 1|X)− P(Dt0,gc = 1|X))
P(Dt1,gt = 1|X)
.
Therefore,
DIDXY + E(Yt0,gt −M |D = 1, X)× P(Dt0,gt = 1|X) + min(X)
P(Dt1,gt = 1|X)
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is a lower bound to ATTXt1,gc . Plugging this lower bound into (5) yields that∫
DIDXY + E(Yt0,gt −M |D = 1, X)× P(Dt0,gt = 1|X) + min(X)
P(Dt1,gt = 1|X)
dP (X|Dt1,gt = 1)
is a lower bound for ATTt1,gt . Using the same steps as those used to prove equation (11), one
can show that this lower bound rewrites
WDIDY +ATTt0,gt × P(Dt0,gt = 1) +
∫
min(X)dP (Xgt)
P(Dt1,gt = 1)
. (15)
Then, ∫
min(X)dP (Xgt)
=
∫
1{t1}(X)E(Yt1,gc −M |D = 1, X)× (P(Dt1,gc = 1|X)− P(Dt0,gc = 1|X)) dP (Xgt)
+
∫
1{t0}(X)E(Yt1,gc −m|D = 1, X)× (P(Dt1,gc = 1|X)− P(Dt0,gc = 1|X)) dP (Xgt)
=
∫
E
(
1{t1}(X) (Yt1,gc −M)
(
1− pX) |D = 1, X)P(Dt1,gc = 1|X)dP (Xgt)
+
∫
E
(
1{t0}(X) (Yt1,gc −m)
(
1− pX) |D = 1, X)P(Dt1,gc = 1|X)dP (Xgt)
=
∫
E
(
1{t1}(X) (Yt1,gc −M)
(
1− pX)D|X) dP (Xgt)
+
∫
E
(
1{t0}(X) (Yt1,gc −m)
(
1− pX)D|X) dP (Xgt)
=
∫
E
(
1{t1}(X) (Yt1,gc −M)
(
1− pX)DwX |X) dP (Xgc)
+
∫
E
(
1{t0}(X) (Yt1,gc −m)
(
1− pX)DwX |X) dP (Xgc)
= E
(
1{t1}(X) (Yt1,gc −M)
(
1− pX)DwX)+ E (1{t0}(X) (Yt1,gc −m) (1− pX)DwX)
= E
(
min
(
(Yt1,gc −M)
(
1− pX) ; (Yt1,gc −m) (1− pX))wX |D = 1)× P(Dt1,gc = 1).
= Emin × P(Dt1,gc = 1).
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The first equality comes from the fact that
min(X) = 1{t1}(X)E(Yt1,gc −M |D = 1, X) (P(Dt1,gc = 1|X)− P(Dt0,gc = 1|X))
+1{t0}(X)E(Yt1,gc −m|D = 1, X)× (P(Dt1,gc = 1|X)− P(Dt0,gc = 1|X))
because min(X) = 0 when P(Dt1,gc = 1|X) = P(Dt0,gc = 1|X). The second equality hold
because I have assumed that P(Dt1,gc = 1|X) > 0 ⇔ P(Dt0,gc = 1|X) > 0 with probability
one. Finally, the fourth equality holds because of Bayes’ law. Combining the last equality
with (15), I get that
WDIDY +ATTt0,gt × P(Dt0,gt = 1) + Emin × P(Dt1,gc = 1)
P(Dt1,gt = 1)
is a lower bound for ATTt1,gt . This lower bound can be rewritten:
WDIDY 3−
P(Dt1,gt = 1)
.
If ATTXt1,gc = ATT
X
t0,gc , (6) also rewrites as
ATTXt1,gt =
DIDXY +ATT
X
t0,gt × P(Dt0,gt = 1|X) +ATTXt0,gc (P(Dt1,gc = 1|X)− P(Dt0,gc = 1|X))
P(Dt1,gt = 1|X)
.
Then, following the same steps as above, one can show that
WDIDY 4−
P(Dt1,gt = 1)
is also a lower bound for ATTt1,gt , hence the result.
QED.
Proof of Theorem 3.1
The moment inequality model in Andrews & Soares (2010) is based on the following assump-
tions. The parameter of interest θ0 and the true distribution of the data F0 are assumed to
belong to a parameter space F = (θ, F ) such that:
i) θ ∈ R
ii) The data Wi are iid.
iii) EF (mj (W, θ, η)) ≥ 0 for j = 1, ..., p, where mj are known real-valued functions, and η is
a parameter. η should be identified, and there should exist a consistent and asymptotically
normal estimator of it.
iv) σ2F,j (θ) = VF (mj (W, θ, η)) ∈ (0,+∞)
Let m (W, θ, η) = (m1 (W, θ, η) , ...,mp (W, θ, η))′ ,
ΣF (θ) = VF (m (W, θ, η)) ,
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DF (θ) = Diag (ΣF ) ,
ΩF (θ) = D
− 1
2 (θ) Σ (θ)D−
1
2 (θ) ,
mn,j (θ) =
1
n
n∑
i=1
mj (Wi, θ, η̂n (θ)) for j = 1, ..., p,
mn (θ) = (mn,1 (θ) , ...,mn,p (θ))
′ ,
Σ̂n (θ) =
1
n
n∑
i=1
(m (Wi, θ, η̂n)−mn (θ)) (m (Wi, θ, η̂n)−mn (θ))′ ,
σ̂n,j (θ) =
[
Σ̂n (θ)
]
j,j
,
and
D̂n (θ) = Diag
(
Σ̂n (θ)
)
.
For all sequences (θn, Fn) in F such that
θn →
n→+∞ θ,
Fn →
n→+∞ F,
ΩFn →n→+∞ ΩF ,
and
√
nσ−1Fn,j (θn)EFn (mj (W, θn, η)) →n→+∞ hj ∈ R+, we should have that
v) An = (An,1, ..., An,p)′ →
d
Z ∼ N (0k,ΩF ) as n→ +∞, where
An,j =
√
nσ−1Fn,j
(
mn,j (θn)− 1
n
n∑
i=1
EFn (mj (W, θn, η))
)
vi) σ̂n,j(θn)σFn,j(θn) →p 1 when n→ +∞ for j = 1 to p.
vii) D̂−
1
2
n (θn) Σ̂n (θn) D̂
− 1
2
n (θn)→ ΩF when n→ +∞.
As Andrews & Guggenberger (2010) show in their 2nd lemma, a sufficient condition for v),
vi) and vii) to hold is the following condition:
viii) EF
(
|mj (W, θ, η)|2+δ
)
< K for some δ > 0, where K is a constant.
Finally, for the confidence interval not to be conservative, the following assumption should be
verified:
ix) EF (mj (W, θ, η)) = 0 for some j and some (θ, F ) ∈ F .
Therefore, I show now that my model can be rewritten as a moment inequality model which
verifies assumptions i)-iv) and viii)-ix). W = (Y, T,G,D). Let η1 = P(T = 1, G = 1),
η2 = P(T = 0, G = 1), η3 = P(T = 1, G = 0), η4 = P(T = 0, G = 0) and η = (η1, η2, η3, η4) .
As shown in section 2, Y 0− and Y 0+ can be written as functions f0− and f0+ of the data. Let
g(x, η) = TGxη1 −
(1−T )Gx
η2
− T (1−G)xη3 +
(1−T )(1−G)x
η4
.
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Assumption i) and ii) hold because ATTt1,gt ∈ R and the data is iid.
(10) is equivalent to
EF0 (mj (W, θ0, η)) ≥ 0
for j = 1 to 4, with
m1 (W, θ0, η) =
TGD
η1
θ0 − g(f0−(W ), η)
m2 (W, θ0, η) = TGD (θ0 − (Y −M))
m3 (W, θ0, η) = g(f
0
+(W ), η)− TGDθ0
m4 (W, θ0, η) = TGD (Y −m− θ0) .
Moreover, η is identified and can be consistently estimated with an asymptotically normal
estimator. This implies that iii) holds.
Using the triangle inequality, the fact that Y (0) and Y (1) are bounded, that min(η1, η2, η3, η4) ≥
 and that x 7→ x2+δ is increasing on R+, it is easy to show that EF
(
|mj (W, θ, η)|2+δ
)
≤ Kj
where theKj write as functions ofm,M ,m′,M ′, δ and . SettingK = max (K1,K2,K3,K4)+
1, viii) is verified.
viii) implies that EF
(
|mj (W, θ, η)|2
)
< +∞ so that σ2F,j (θ) < +∞, and 0 < σ2F,j (θ) for non
degenerate distributions. Therefore iv) holds.
Finally, sharpness of the bounds implies that ix) holds.
QED.
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